Application of Artificial Intelligence and Machine Learning in Libraries: A Systematic Review

As the concept and implementation of cutting-edge technologies like artificial intelligence and machine learning has become relevant, academics, researchers and information professionals involve research in this area. The objective of this systematic literature review is to provide a synthesis of empirical studies exploring application of artificial intelligence and machine learning in libraries. To achieve the objectives of the study, a systematic literature review was conducted based on the original guidelines proposed by Kitchenham et al. (2009). Data was collected from Web of Science, Scopus, LISA and LISTA databases. Following the rigorous/ established selection process, a total of thirty-two articles were finally selected, reviewed and analyzed to summarize on the application of AI and ML domain and techniques which are most often used in libraries. Findings show that the current state of the AI and ML research that is relevant with the LIS domain mainly focuses on theoretical works. However, some researchers also emphasized on implementation projects or case studies. This study will provide a panoramic view of AI and ML in libraries for researchers, practitioners and educators for furthering the more technology-oriented approaches, and anticipating future innovation pathways

An Integrated Deep Learning and Belief Rule-Based Expert System for Visual Sentiment Analysis under Uncertainty

Visual sentiment analysis has become more popular than textual ones in various domains for decision-making purposes. On account of this, we develop a visual sentiment analysis system, which can classify image expression. The system classifies images by taking into account six different expressions such as anger, joy, love, surprise, fear, and sadness. In our study, we propose an expert system by integrating a Deep Learning method with a Belief Rule Base (known as the BRBDL approach) to assess an image’s overall sentiment under uncertainty. This BRB-DL approach includes both the data-driven and knowledge-driven techniques to determine the overall sentiment. Our integrated expert system outperforms the state-of-the-art methods of visual sentiment analysis with promising results. The integrated system can classify images with 86% accuracy. The system can be beneficial to understand the emotional tendency and psychological state of an individual.Validerad;2021;Nivå 2;2021-07-16 (johcin)</p

A Belief Rule Base Approach to Support Comparison of Digital Speech Signal Features for Parkinson’s Disease Diagnosis

Parkinson’s disease is a neurological disorder. It affects the structures of the central and peripheral nervous system that control movement. One of the symptoms of Parkinson’s disease is difficulty in speaking. Hence, analysis of speech signal of patients may provide valuable features for diagnosing. Previous works on diagnosis based on speech data have employed machine learning and deep learning techniques. However, these approaches do not address the various uncertainties in data. Belief rule based expert system (BRBES) is an approach that can reason under various forms of data uncertainty. Thus, the main objective of this research is to compare the potential of BRBES on various speech signal features of patients of parkinson’s disease. The research took into account various types of standard speech signal features such MFCCs, TQWTs etc. A BRBES was trained on a dataset of 188 patients of parkinson’s disease and 64 healthy candidates with 5-fold cross validation. It was optimized using an exploitive version of the nature inspired optimization algorithm called BRB-based adaptive differential evolution (BRBaDE). The optimized model performed better than explorative BRBaDE, genetic algorithm and MATLAB’s FMINCON optimization on most of these features. It was also found that for speech based diagnosis of Parkinson’s disease under uncertainty, the features such as Glottis Quotient, Jitter variants, MFCCs, RPDE, DFA and PPE are relatively more suitable. ISBN för värdpublikation: 978-3-030-86992-2; 978-3-030-86993-9</p

Thigh-length compression stockings and DVT after stroke

Controversy exists as to whether neoadjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite randomised controlled trials of more than 3000 patients. We undertook a systematic review and meta-analysis to assess the effect of such treatment on survival in patients with this disease

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19. Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospital with COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients were randomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once per day by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatment groups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment and were twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants and local study staff were not masked to the allocated treatment, but all others involved in the trial were masked to the outcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) were eligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was 65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomly allocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall, 561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days (rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median 10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days (rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, no significant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilation or death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24). Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or other prespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restricted to patients in whom there is a clear antimicrobial indication. Funding UK Research and Innovation (Medical Research Council) and National Institute of Health Research